Bayer announced the appointment of Dr. Carsten Brunn as President of its Pharmaceuticals business in the Americas, comprising the United States, Canada, Central and Latin America. In this role, Dr. Brunn will report to Dieter Weinand, member of the Board of Management of Bayer AG and President of the Pharmaceutical division. Previously, Dr. Brunn was Head of Bayer's Pharmaceuticals Commercial Operations in Japan, a role he held since 2013.